Page 4,328«..1020..4,3274,3284,3294,330..4,3404,350..»

New form of treatment to reduce risk of surgery-related ischemic brain injury?

Posted: Published on May 3rd, 2014

Ischemic brain injury due to heart and vascular surgery cause more than 100,000 deaths annually in Europe and the United States. In addition, approximately 10-20% of patients undergoing heart and vascular surgery -- at least 1.5 million people in Europe and the United States every year -- suffer from ischemic brain injury as a side-effect of their surgery. Researchers from the Institute of Biotechnology at the University of Helsinki, Finland, have found that water-only fasting or protein-free diet before stroke reduce the amount of damaged brain tissue in rats by nearly 40%. Academy Research Fellow Jaan-Olle Andressoo notes that reducing brain damage caused by surgery, some of which results in what are known as "silent strokes," would be extremely important. A silent stroke, often left undiagnosed, may disrupt the brain's capacity to process information. Patients may experience cognitive difficulties after heart surgery, e.g. find that they can no longer complete everyday tasks as easily as before. "Minimising brain damage is the main target of our research, and we are now seeking partners to enable us to test the pre-surgery diets on patient groups." Academy Research Fellow Kaisa Hartikainen, a neurologist at the Behavioural Neurology Research Unit at the Tampere University … Continue reading →

Posted in Brain Injury Treatment | Comments Off on New form of treatment to reduce risk of surgery-related ischemic brain injury?

Pregnancy hormone could offer simple treatment for MS

Posted: Published on May 3rd, 2014

A pregnancy hormone could prove a simple way to treat multiple sclerosis, after showing promise in a trial of 158 women with MS. MS is a neurological condition that results from damage to the brain and nerves inflicted by the body's own immune system. It affects 2.3 million people worldwide. Symptoms include extreme tiredness, blurred vision, muscle weakness and problems with balance and movement. The symptoms of women with MS tend to ease when they are pregnant, but worsen again after giving birth. This could be because of a hormone called oestriol, which is only produced in significant amounts during pregnancy. The hormone is thought to help suppress the mother's immune system to prevent it attacking the fetus. Rhonda Voskuhl of the University of California, Los Angeles, and her colleagues wondered whether giving oestriol to people with MS who aren't pregnant might also help with symptoms. They gave 8 milligrams of oestriol daily to 86 women with MS, along with their medication, Copaxone (glatiramer acetate). The women had the most common form of MS, called relapsing-remitting MS, which results in periodic flare-ups of symptoms followed by recovery. After one year, they had 47 per cent fewer relapses than a control … Continue reading →

Posted in MS Treatment | Comments Off on Pregnancy hormone could offer simple treatment for MS

Stem Cell Research & Human Dignity – Video

Posted: Published on May 3rd, 2014

Stem Cell Research Human Dignity A preview of Moral Compass : Stem Cell Research Human Dignity This is a free preview of the full episode; to see the full version, sign up for a Premium ac... By: ChurchMilitantTV … Continue reading →

Posted in Stem Cell Research | Comments Off on Stem Cell Research & Human Dignity – Video

Stem Cell Research Public Service Announcement – Video

Posted: Published on May 3rd, 2014

Stem Cell Research Public Service Announcement Digital PSA for University of Kentucky's WRD111 Course. Songs: Fix You - Coldplay Beautiful Day - U2 (used without permission) Works Cited "Neuralstem Cell T... By: Kirstie Kleiner … Continue reading →

Posted in Stem Cell Research | Comments Off on Stem Cell Research Public Service Announcement – Video

Stem Cell Research Period 2 – Video

Posted: Published on May 3rd, 2014

Stem Cell Research Period 2 Biology. By: Abby7674 … Continue reading →

Posted in Stem Cell Research | Comments Off on Stem Cell Research Period 2 – Video

Soft substrates may promote the production of induced pluripotent stem cells

Posted: Published on May 3rd, 2014

17 hours ago Figure 1: Fluorescence microscopy image of cells cultured on soft (left) and rigid (right) substrates. Actin filaments (red) in these cells display dramatic differences in number and organization depending on substrate elasticity. Credit: The Society for Biotechnology, Japan Converting adult cells into stem cells that can develop into other types of specialized cells is one of the most active areas of medical research, holding great promise for the treatment of disease and repair of damaged tissues. The techniques available for reprogramming adult cells into stem cells, however, remain imperfect and inefficient. In research that could help improve reprogramming efficiency, Sayaka Higuchi and colleagues from the RIKEN Quantitative Biology Center have now found that culturing cells on soft or elastic substrates enhances expression of some of the markers of stem cell reprogramming. Motivated by previous observations that culturing cells on soft surfaces can affect their ability to multiply and renew, Higuchi and her team set out to examine whether the same principle might be applicable to enhancing the efficiency of producing induced pluripotent stem (iPS) cellsa type of stem cell that is reprogrammed from mature adult fibroblast cells using methods such as the introduction of genetic factors. The … Continue reading →

Posted in Stem Cell Research | Comments Off on Soft substrates may promote the production of induced pluripotent stem cells

Stem Cell Therapy Market (Autologous & Allogeneic) Worth $330 Million in 2020 – New Report by MarketsandMarkets

Posted: Published on May 3rd, 2014

(PRWEB) May 02, 2014 The report Stem Cell Therapy Market by Treatment Mode (Autologous & Allogeneic), Therapeutic Applications (CNS, CVS, GIT, Wound Healing, Musculoskeletal, Eye, & Immune System) - Regulatory Landscape, Pipeline Analysis & Global Forecasts to 2020 analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Asia-Pacific, Europe, and the Rest of the World (RoW). Browse 57 market data tables 32 figures spread through 196 Slides and in-depth TOC on Stem Cell Therapy Market http://www.marketsandmarkets.com/Market-Reports/stem-cell-technologies-and-global-market-48.html Early buyers will receive 10% customization on report. This report studies the global stem cell therapy market over the forecast period of 2015 to 2020.The market is poised to grow at a CAGR of 39.5% from 2015 to 2020, to reach $330million by 2020. Download Free PDF Download @ http://www.marketsandmarkets.com/pdfdownload.asp?id=48 The global stem cell therapy market on the basis of the mode of treatment is segmented into allogeneic and autologous stem cell therapy. In addition, based on the therapeutic applications, the global stem cell therapy market is segmented into eye diseases, metabolic diseases, GIT diseases, musculoskeletal disorders, immune system diseases, CNS diseases, CVS diseases, wounds and injuries, and others. Inquire Before Buying @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=48 A number of factors such … Continue reading →

Comments Off on Stem Cell Therapy Market (Autologous & Allogeneic) Worth $330 Million in 2020 – New Report by MarketsandMarkets

Additional Tickets Released for Stem Cell Institute Public Seminar on Adult Stem Cell Therapy Clinical Trials in New …

Posted: Published on May 3rd, 2014

New York, NY (PRWEB) May 02, 2014 Stem Cell Institute is releasing additional tickets for its Adult Stem Cell Therapy Clinical Trials seminar on Saturday, May 17, 2014 in New York City at the New York Hilton Midtown from 1:00 pm to 4:00 pm. After booking its original meeting room beyond capacity, the Stem Cell Institute has reserved a larger room to accommodate additional attendees. The seminar will now take place in the Beekman Room, 2nd Floor, East Corridor of the New York Hilton Midtown. Those interested in attending are encouraged to register promptly. Only 75 additional seats are available. Speakers include: Neil Riordan PhD Clinical Trials: Umbilical Cord Mesenchymal Stem Cell Therapy for Autism and Spinal Cord Injury Dr. Riordan is the founder of the Stem Cell Institute and Medistem Panama Inc. Jorge Paz-Rodriguez MD Stem Cell Therapy for Autoimmune Disease: MS, Rheumatoid Arthritis and Lupus Dr. Paz is the Medical Director at the Stem Cell Institute. He practiced internal medicine in the United States for over a decade before joining the Stem Cell Institute in Panama. Special guest speaker: See the original post: Additional Tickets Released for Stem Cell Institute Public Seminar on Adult Stem Cell Therapy Clinical … Continue reading →

Comments Off on Additional Tickets Released for Stem Cell Institute Public Seminar on Adult Stem Cell Therapy Clinical Trials in New …

Ophthalmic Acupuncture for Retinitis Pigmentosa – Video

Posted: Published on May 2nd, 2014

Ophthalmic Acupuncture for Retinitis Pigmentosa Naomi Jansson explains how the Australian Centre for Natural Medicine on the Gold Coast uses ophthalmic acupuncture for treating retinitis pigmentosa. By: Alan Jansson … Continue reading →

Posted in Retinitis Pigmentosa | Comments Off on Ophthalmic Acupuncture for Retinitis Pigmentosa – Video

Stem Cells Used to Regenerate Heart Muscle in Monkeys

Posted: Published on May 2nd, 2014

WEDNESDAY, April 30, 2014 (HealthDay News) -- Scientists who used human embryonic stem cells to regenerate damaged heart muscle in monkeys say this technique could be ready for human clinical trials within four years. If the research proves successful, it could provide a way to restore normal function in failing hearts, according to the researchers. Before this study, it wasn't known if it would be "possible to produce sufficient numbers of these cells and successfully use them to remuscularize damaged hearts in a large animal whose heart size and physiology is similar to that of the human heart," team leader Dr. Charles Murry, professor of pathology and bioengineering at the University of Washington in Seattle, said in a university news release. Murry and his colleagues triggered heart attacks in anesthetized macaque monkeys and two weeks later injected 1 billion heart muscle cells derived from human embryonic stem cells into the damaged areas of the heart. That amount of cells was 10 times greater than what the researchers had previously been able to create. The monkeys received immune system-suppressing drugs to prevent rejection of the transplanted human cells. Within a few weeks, the new heart muscle cells matured and began to … Continue reading →

Posted in Stem Cell Human Trials | Comments Off on Stem Cells Used to Regenerate Heart Muscle in Monkeys

Page 4,328«..1020..4,3274,3284,3294,330..4,3404,350..»